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THE SPEED MODULATION OF THE
PATIENT'S ROTATION IN TSEI-RD
TO IMPROVE THE HOMOGENEITY
OF THE DOSE DISTRIBUTION
IN THE HORIZONTAL PLANE.
IN PHANTOM'S RESULTS
Piotrowski T.
Zaktad Fizyki Medycznej,
Wielkopolskie Centrum Onkologii, Poznan
Purpose: The aim of this study was to
reduce the differences in doses accumu-
lated in the points, localised in the same
horizontal plane, on the patient's skin,
during the rotary-dual total skin electron
irradiation (TSEI RD).
Material and Method: During the
standard TSEI RD technique, the patient
was standing on the slowly and
continuously rotating platform while the
irradiation with two dual electron fields was
performed. In this study a non-continuous
platform movement was implemented.
One cylindrical (diameter of 30 cm) and
two elliptical (diameters of 20/40 cm and
25/35 cm) wax phantoms were used. The
one full circle (360 degree) of the platform
was divided into eight fractions. The
platform speed was calculated individually
for the each fraction. The total time of one
rotation in both modes of the movements:
continuous and non-continuous were
equal. Phantoms were irradiated with two
dual fields: size of 36x36 cm at the
isocenter each, source-phantom distance
of 300 cm, and with 6 MeV electrons'
energy (output). Doses were measured
with the semiconductor detectors which
were placed -equidistantly (distance
between dosimetrical points by 45 degree)
on the same horizontal plane on the
phantom's surface.
Results: The respective measured
doses after normalisation to those pre-
viously calculated were as follows: 1/ for
the cylindrical phantom (diameter of 30
cm) - 100.1%, 99.8%, 100.3%, 99.4%,
100.1%,99.8%, 100,3%,99.4%;2/ for the
elliptical phantom of 25/35 cm - 98.3%,
99.6%, 103.2%, 99.2%, 97.8%, 99.6%,
103.2%, 100.7% and 3/ for the elliptical
phantom of 20/40 cm - 95.8%, 99.9%,
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105%, 98.8%, 95.8%, 100.2%, 105%,
99.3%. The modulation of the speed
during platform's rotation resulted in the
decrease of the dose discrepancies. The
respective measured doses after the
normalization performed with the same as
above way were equal to: 1/ for the
elliptical phantom of 25/35 cm - 99.4%,
99.9%, 101.3%, 100.5%, 100.1 %, 100.9%,
101.1%, 99.7%; 2/ for the elliptical
phantom of 20/40cm - 98.9%, 100.2%,
102.4%, 99.8%, 99%, 99.9%, 102.1%,
100.5%.
Conclusion: Results of the dose in-
phantom measurements showed that the
speed modulation of the platform reduced
the dose inhomogeneity at the horizontal
plane on the phantom's surface.
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Background: Multiple clinical trials had
proven that endovascular brachytherapy
can reduce the risk of restenosis from 30-
60% to 5-15% if radiotherapy is planned
and performed correctly. One of the most
important parameter for the treatment
planning is reference isodose length (RIL)
defined as a vessel length at the reference
depth (RD) covered by 90 % isodose. RIL
depends on the source configuration -
active source length (ASL), step times and
reference depth. The reference isodose
length must be greater or equal to
planning target length (PTL) therefore the
maximum intervention length (IL) must be
smaller then RIL - 10 mm for safety
margin.
Material and Method: The MicroSelec-
tron HDR with Ir-192 source and the 5F
catheter was used for treatment delivery.
The dose distributions were calculated at
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Plato ver. 14.1.3, and then optimised by
internal algorithm for active source length
of 10 cm (21 step positions) and reference
depths of 5, 7 and 10 mm. TLD chips L1F
100 were used as the detectors after
calibration in Co-60 photon beam and
Harshaw 3500 as a reader. The catheter
and TLD chips were placed in a wax-
parafin phantom assuring the distance
from the catheter to detectors equal to the
reference depth (5, 7 and 10 mm). The
measurements were preformed twice for
every depth - for the non optimised
treatment plan and for the plan with
optimisation algorithm applied. The dose
delivered at the reference distance was
10 Gy.
Results. The treatment plan was
calculated for the active source length
(ASL) of 10 cm. The RIL values calculated
without optimisation of the step times,
were: 8.9 cm, 9.28 cm and 8.96 cm.
The measured RIL were: 8.64 cm, 9.6 cm,
8.32 cm (+/- 0.32 cm), for the RD = 5, 7
and 10 cm, respectively. For the optimised
treatment plan, the calculated RIL were:
10.24 cm, 10.56 cm and 10.56 cm while
the measured RIL were 10.24 cm,
10.56 cm and 9.92 cm (+/- 0.32 cm),
for the RD = 5, 7 and 10 cm, respectively.
The RIL measured during the treatment
carried according to the optimised plan
were by 1.60 cm, 0.96 cm and 1.60 cm
longer then those for the treatment made
without optimisation at the reference
depths. The increase of the dose
measured at the last distal and proximal
position of the application were 35, 38 and
37% for RD = 5, 7 and 10 cm,
respectively.
Conclusion. Optimisation of the
treatment plan is the main tool for the
accurate trealment delivery in
endovascular brachytherapy. The TLD
dosimeters showed the increase of the
dose at distal and proximal parts of the
active length (AL), and thus optimisation
algorithm built in Plato ver. 14.1.3 has
been proven to be correct for the above
clinical situation.
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THE FREQUENT AND PRECISE
MONITORING OF MUCOSAL
REACTION DURING RADIATION
THERAPY IN HEAD AND NECK
CANCER PATIENTS AFFORDS
POSSIBILITIES OF QUANTITATIVE
REPORTING AND PREDICTING ITS
SEVERITY
WygodaA.
I Radiotherapy Clinic, Centre of Oncology
- MSC Memorial Institute in Gliwice
Background. Numerous prospective
clinical studies on acute radiation mucosal
toxicity have been doing over the last 10
years in Gliwice Oncology Centre.
Consequence of those experiences is the
policy of detailed monitoring and reporting
of many objective and sUbjective
symptoms estimating the incidence and
pattern of radiation mucositis.
Aim. To evaluate clinical and treatment-
related factors influencing on duration of
healing, incidence and severity of
mucositis and overall duration of acute
mucosal reaction.
Material and Methods. The unique data
set of careful and frequent observations of
mucosal radiation reaction in 88 con-
secutive patients (pts) with head and neck
cancer treated by radiation alone have
been included into the analysis. There
were 35 pts treated by conventional
fractionation with 2.0Gy per fraction and 4
pts with 2.5Gy per fraction (CF), 33 pts
treated by accelerated fractionation
(CAIR), 8 pts by hyperfractionation (HF),
and 8 pts· with glottic T1 cancer treated by
hypofractionation of 3Gy per day (hF). All
patients have been observed everyday
with examination of oral cavity, pharynx
and larynx done 3 times weekly, by the
same, well experienced radiation
oncologist, according to the own scoring
system based on the Dische' suggestions.
The monitoring of mucosal reaction has
been always beginning at the 1st day of
treatment, before radiation fraction,
followed after the end of treatment, up to
the disappearance of any symptom
(except xerostomia), what was identified
as a complete healing of mucosa.
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